Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price reached a new 52-week low on Friday after StockNews.com downgraded the stock from a hold rating to a sell rating. The stock traded as low as $65.67 and last traded at $66.72, with a volume of 148079 shares changing hands. The stock had previously closed at $66.73.

Several other brokerages have also recently issued reports on ACHC. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a research report on Friday, January 5th. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a research report on Thursday, April 25th. Finally, Mizuho dropped their price target on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average price target of $88.89.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare in the 4th quarter worth approximately $26,000. Headlands Technologies LLC purchased a new stake in Acadia Healthcare in the 3rd quarter valued at approximately $25,000. Mather Group LLC. purchased a new stake in Acadia Healthcare in the 1st quarter valued at approximately $48,000. Fifth Third Bancorp lifted its stake in Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare in the 3rd quarter valued at approximately $96,000.

Acadia Healthcare Trading Down 0.9 %

The company has a current ratio of 1.27, a quick ratio of 0.67 and a debt-to-equity ratio of 0.63. The business has a 50 day moving average of $76.77 and a 200-day moving average of $77.52. The stock has a market cap of $6.11 billion, a PE ratio of -472.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. During the same quarter in the prior year, the company earned $0.75 EPS. Acadia Healthcare’s revenue was up 9.1% on a year-over-year basis. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.